West Chester, Ohio based AtriCure has received 510(k) clearance for its AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion system, an implantable clip for the occlusion of the left atrial appendage (LAA). AtriClip is designed to be implanted from the outside of the heart, avoiding contact with circulating blood and eliminating blood flow between the LAA and the atria. Under direct visualization and in conjunction with other open-heart cardiac procedures, the device can help reduce blood clots that could lead to strokes in patients with atrial fibrillation (AF).
From the product pages:
Dynamic closure of the LAA with atraumatic tissue compression, permanent orifice closure and full tissue absorption. Enclosed woven polyester fabric that is used extensively in cardiac procedures. Malleable shaft and articulating distal mechanism enables precise delivery, and can easily be repositioned prior to suture release.
AtriCure’s press statement: AtriCure’s AtriClip System Receives FDA 510(k) Clearance…
Product page: AtriClip Gillinov-Cosgrove LAA Exclusion System…
Product brochure: AtriClip… (.pdf)